{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:40:33Z","timestamp":1780987233834,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.surg.2025.109828","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:56:18Z","timestamp":1761303378000},"page":"109828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in peritoneal sarcomatosis: Therapeutic advancement or clinical controversy? An institutional review"],"prefix":"10.1016","volume":"190","author":[{"given":"M.D.","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8212-7547","authenticated-orcid":false,"given":"Rohan","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2025.109828_bib1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ejso.2021.10.013","article-title":"Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal sarcomatosis-A systematic review and meta-analysis","volume":"48","author":"Wong","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.surg.2025.109828_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1245\/s10434-010-1229-3","article-title":"Systematic review on the efficacy of multimodal treatment of sarcomatosis with cytoreduction and intraperitoneal chemotherapy","volume":"18","author":"Munene","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2025.109828_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijscr.2019.09.009","article-title":"Long-term survival is possible using cytoreductive surgery plus HIPEC for sarcomatosis\u2014case report of 2 patients","volume":"64","author":"Sugarbaker","year":"2019","journal-title":"Int J Surg Case Rep"},{"key":"10.1016\/j.surg.2025.109828_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0300594","article-title":"Radical resection and hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of high risk recurrent retroperitoneal sarcoma\u2014A pilot study in a tertiary Asian centre","volume":"19","author":"Seo","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.surg.2025.109828_bib5","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1245\/s10434-023-14786-5","article-title":"Cytoreductive surgery with bidirectional intraoperative chemotherapy (BDIC) using intravenous ifosfamide plus hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal sarcomatosis: a retrospective cohort study","volume":"31","author":"Almasri","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2025.109828_bib6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.surg.2025.109828_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<66::AID-CNCR10>3.0.CO;2-0","article-title":"Salvage surgery for patients with recurrent gastrointestinal sarcoma: prognostic factors to guide patient selection","volume":"88","author":"Mudan","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2025.109828_bib8","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1245\/s10434-012-2240-7","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal sarcomatosis","volume":"19","author":"Salti GI, Ailabouni L, Undevia S","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2025.109828_bib9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ciresp.2024.05.006","article-title":"Radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal sarcomatosis: results from a reference center and considerations based on current evidence","volume":"102","author":"Mu\u00f1oz Casares","year":"2024","journal-title":"Cir Esp (Engl Ed)"},{"key":"10.1016\/j.surg.2025.109828_bib10","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1245\/s10434-010-1178-x","article-title":"Peritoneal sarcomatosis: is there a subset of patients who may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?","volume":"17","author":"Baratti","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2025.109828_bib11","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ejso.2005.04.010","article-title":"Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis","volume":"31","author":"Bonvalot","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.surg.2025.109828_bib12","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.21037\/jgo.2018.08.19","article-title":"A simplified peritoneal sarcomatosis score for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"9","author":"Naffouje","year":"2018","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.surg.2025.109828_bib13","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3390\/cancers15041340","article-title":"Treatment pathways and prognosis in advanced sarcoma with peritoneal sarcomatosis","volume":"15","author":"Klingler","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.surg.2025.109828_bib14","series-title":"Holland-Frei Cancer Medicine","year":"2003"},{"key":"10.1016\/j.surg.2025.109828_bib15","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.ejso.2017.08.011","article-title":"Multi-institutional study of peritoneal sarcomatosis from uterine sarcoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"43","author":"Sardi","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.surg.2025.109828_bib16","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.ejso.2019.05.008","article-title":"Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin","volume":"45","author":"Munoz-Zuluaga","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.surg.2025.109828_bib17","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/sj.bjc.6690781","article-title":"Body weight and risk of soft-tissue sarcoma","volume":"81","author":"Tavani","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.surg.2025.109828_bib18","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ygyno.2009.08.014","article-title":"Hormone receptor expression in uterine sarcomas: prognostic and therapeutic roles","volume":"115","author":"Ioffe","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.surg.2025.109828_bib19","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1200\/JCO.2002.11.050","article-title":"Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial","volume":"20","author":"Hensley","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2025.109828_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2147\/CMAR.S343467","article-title":"Prediction of peritoneal cancer index and prognosis in peritoneal metastasis of gastric cancer using NLR-PLR-DDI score: a retrospective study","volume":"14","author":"Ye","year":"2022","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.surg.2025.109828_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7800-2-3","article-title":"Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer","volume":"2","author":"Harmon","year":"2005","journal-title":"Int Semin Surg Oncol"},{"key":"10.1016\/j.surg.2025.109828_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s13193-018-0782-2","article-title":"Cytoreductive surgery in combination with HIPEC in the treatment of peritoneal sarcomatosis","volume":"10","author":"Karamveri","year":"2019","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.surg.2025.109828_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s13193-016-0504-6","article-title":"Complications of cytoreductive surgery and HIPEC in the treatment of peritoneal metastases","volume":"7","author":"Mehta","year":"2016","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.surg.2025.109828_bib24","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ejso.2021.10.013","article-title":"Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal sarcomatosis\u2014a systematic review and meta-analysis","volume":"48","author":"Wong","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.surg.2025.109828_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5468\/ogs.2019.62.2.103","article-title":"Prognostic factors for recurrence and survival in uterine leiomyosarcoma: Korean single center experience with 50 cases","volume":"62","author":"Paik","year":"2019","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.surg.2025.109828_bib26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0959-8049(98)00375-X","article-title":"Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment","volume":"35","author":"Berthet","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.surg.2025.109828_bib27","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.3390\/cancers16152646","article-title":"Ibero-American consensus for the management of peritoneal sarcomatosis: updated review and clinical recommendations","volume":"16","author":"Mu\u00f1oz-Casares","year":"2024","journal-title":"Cancers (Basel)"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606025006804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606025006804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T08:23:08Z","timestamp":1780820588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606025006804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":27,"alternative-id":["S0039606025006804"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2025.109828","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in peritoneal sarcomatosis: Therapeutic advancement or clinical controversy? An institutional review","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2025.109828","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109828"}}